158 related articles for article (PubMed ID: 8857599)
1. [3H]MDL 100,907: a novel selective 5-HT2A receptor ligand.
Johnson MP; Siegel BW; Carr AA
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):205-9. PubMed ID: 8857599
[TBL] [Abstract][Full Text] [Related]
2. [3H]MDL 100,907 labels 5-HT2A serotonin receptors selectively in primate brain.
López-Giménez JF; Vilaró MT; Palacios JM; Mengod G
Neuropharmacology; 1998 Sep; 37(9):1147-58. PubMed ID: 9833645
[TBL] [Abstract][Full Text] [Related]
3. Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907.
López-Giménez JF; Mengod G; Palacios JM; Vilaró MT
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):446-54. PubMed ID: 9349630
[TBL] [Abstract][Full Text] [Related]
4. Antagonist binding at 5-HT(2A) and 5-HT(2C) receptors in the rabbit: high correlation with the profile for the human receptors.
Aloyo VJ; Harvey JA
Eur J Pharmacol; 2000 Oct; 406(2):163-9. PubMed ID: 11020478
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
6. [11C]MDL 100907, a radioligland for selective imaging of 5-HT(2A) receptors with positron emission tomography.
Lundkvist C; Halldin C; Ginovart N; Nyberg S; Swahn CG; Carr AA; Brunner F; Farde L
Life Sci; 1996; 58(10):PL 187-92. PubMed ID: 8602111
[TBL] [Abstract][Full Text] [Related]
7. Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies.
López-Giménez JF; Vilaró MT; Palacios JM; Mengod G
J Comp Neurol; 2001 Jan; 429(4):571-89. PubMed ID: 11135236
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of [m-methoxy 3H]MDL100907 binding to 5HT2A receptors in cerebral cortex and brain stem of streptozotocin induced diabetic rats.
Jackson J; Paulose CS
Mol Cell Biochem; 1999 Sep; 199(1-2):81-5. PubMed ID: 10544955
[TBL] [Abstract][Full Text] [Related]
9. Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile.
Kehne JH; Baron BM; Carr AA; Chaney SF; Elands J; Feldman DJ; Frank RA; van Giersbergen PL; McCloskey TC; Johnson MP; McCarty DR; Poirot M; Senyah Y; Siegel BW; Widmaier C
J Pharmacol Exp Ther; 1996 May; 277(2):968-81. PubMed ID: 8627580
[TBL] [Abstract][Full Text] [Related]
10. Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: blockade by MDL 100,907, a highly selective 5-HT2A receptor antagonist.
Marek GJ; Aghajanian GK
Eur J Pharmacol; 1994 Jul; 259(2):137-41. PubMed ID: 7957607
[TBL] [Abstract][Full Text] [Related]
11. Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.
Sleight AJ; Stam NJ; Mutel V; Vanderheyden PM
Biochem Pharmacol; 1996 Jan; 51(1):71-6. PubMed ID: 8534270
[TBL] [Abstract][Full Text] [Related]
12. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
[TBL] [Abstract][Full Text] [Related]
13. Agonist and antagonist binding to rabbit cortical 5-HT2A receptors: opposite effects of magnesium.
Aloyo VJ; Salt GL; Hoffman ME; Harvey JA
Ann N Y Acad Sci; 1998 Dec; 861():280. PubMed ID: 9928290
[No Abstract] [Full Text] [Related]
14. Human striosomes are enriched in 5-HT2A receptors: autoradiographical visualization with [3H]MDL100,907,[125I](+/-)DOI and [3H]ketanserin.
López-Giménez JF; Mengod G; Palacios JM; Vilaró MT
Eur J Neurosci; 1999 Oct; 11(10):3761-5. PubMed ID: 10564383
[TBL] [Abstract][Full Text] [Related]
15. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
16. PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907.
Ito H; Nyberg S; Halldin C; Lundkvist C; Farde L
J Nucl Med; 1998 Jan; 39(1):208-14. PubMed ID: 9443763
[TBL] [Abstract][Full Text] [Related]
17. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
Lyon RA; Davis KH; Titeler M
Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907.
Hall H; Farde L; Halldin C; Lundkvist C; Sedvall G
Synapse; 2000 Dec; 38(4):421-31. PubMed ID: 11044889
[TBL] [Abstract][Full Text] [Related]
19. Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
Kristiansen H; Elfving B; Plenge P; Pinborg LH; Gillings N; Knudsen GM
Synapse; 2005 Dec; 58(4):249-57. PubMed ID: 16206185
[TBL] [Abstract][Full Text] [Related]
20. Time course of 5-HT2A receptor occupancy in the human brain after a single oral dose of the putative antipsychotic drug MDL 100,907 measured by positron emission tomography.
Gründer G; Yokoi F; Offord SJ; Ravert HT; Dannals RF; Salzmann JK; Szymanski S; Wilson PD; Howard DR; Wong DF
Neuropsychopharmacology; 1997 Sep; 17(3):175-85. PubMed ID: 9272484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
